文献速递中枢神经肿瘤放疗放疗物理与技术

儿童脑肿瘤质子治疗中生物剂量与影像学改变

Biologic Dose and Imaging Changes in Pediatric Brain Tumor Patients Receiving Spot Scanning Proton Therapy.
PubMed 文献 · Int J Radiat Oncol Biol Phys · 2019-07-10

分析发现T2 FLAIR改变体积与生物剂量(BD)体积的重叠显著大于与治疗计划剂量(TPD)体积的重叠,BD模型在治疗计划中或有助于减少关键结构接受过高生物剂量。

要点

  • T2 FLAIR改变与BD105%、BD110%体积中位重叠分别为85%、18%,与TPD105%为0%。
  • BD模型与影像学改变空间重叠优于TPD模型。

核心结论

  • 在笔束扫描质子治疗的儿童脑肿瘤患者中,BD模型与治疗后T2改变体积重叠优于TPD模型。

主要发现

  • T2 FLAIR改变与BD105%、BD110%、TPD105%的中位体积重叠分别为85%、18%、0%。
  • T1C+改变与BD体积重叠呈非显著性增加。
  • BD110%、BD105%或物理剂量105%的总体积与影像学改变发生无相关性。

临床怎么用

  • 笔束扫描质子治疗计划中采用BD模型或有助于避免关键结构接受过高BD,减少放射性晚期效应风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To evaluate the incidence of imaging changes in our pediatric brain tumor population treated with spot-scanning proton therapy and analyze the spatial correlation of imaging changes with a novel biologic dose model. METHODS AND MATERIALS: All pediatric patients treated during the first year of our institution's experience who received a minimum treatment planning dose (TPD) of 5040 cGyE with available follow-up magnetic resonance imaging scans were selected for analysis. Posttreatment magnetic resonance imaging scans were fused with the treatment planning computed tomography. All T1 post-gadolinium enhancement, T2 fluid attenuated inversion recovery changes, TPD, and biologic dose (BD) volumes outside of the original gross tumor volume were contoured for analysis. RESULTS: Thirty patients were included in the analysis, 7 of whom developed posttreatment radiologic changes. The volumetric overlap of the T2 fluid attenuated inversion recovery changes and BD volumes was significantly greater than the overlap with the TPD volumes. Median volumetric overlaps of 85%, 18%, and 0% were observed with the BD105%, BD110%, and TPD105%, respectively. A nonsignificant increase in the volumetric overlap of the T1C+ changes and BD volumes was also observed. No correlation was observed between the total volume of BD110%, BD105%, or physical dose 105% and the development of imaging changes. CONCLUSIONS: Within our pediatric brain tumor population treated with spot-scanning proton therapy, our BD model demonstrated superior volumetric overlap with posttreatment T2 changes compared with the TPD model. Using a BD model in treatment planning for spot-scanning proton therapy may help avoid delivery of excessive BD to critical structures and may help minimize the risk of radiation-related late effects.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Roberts KW, Wan Chan Tseung HS, Eckel LJ, et al. Biologic Dose and Imaging Changes in Pediatric Brain Tumor Patients Receiving Spot Scanning Proton Therapy. Int J Radiat Oncol Biol Phys. 2019. PMID: 31301328. doi:10.1016/j.ijrobp.2019.06.2534

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。